U.S. Attorney Jesse A. Laslovich | U.S. Department of Justice
A Tennessee man has admitted to selling unapproved drugs for bodybuilding through his business, Rat’s Army, based in Kalispell. Tyler Jordan Hall, 31, from Greenville, Tennessee, pleaded guilty to introducing unapproved drugs into interstate commerce on January 9. He faces a potential sentence of up to three years in prison, a $250,000 fine, and one year of supervised release.
U.S. Magistrate Judge Kathleen L. DeSoto presided over the arraignment and set sentencing for May 15 before U.S. District Judge Dana L. Christensen. The court will consider the U.S. Sentencing Guidelines and other statutory factors when determining the sentence.
According to court documents presented by the government, Hall operated Rat’s Army from June 2020 through March 2022 to import and create drugs marketed to bodybuilders for muscle mass increase and fat reduction. These substances contained Selective Estrogen Receptor Modulators (SERMs) and other active pharmaceutical ingredients (API), which were introduced into interstate commerce without approval.
The government stated that many of these substances were unsafe for human use unless administered by a licensed practitioner. Some drugs resembled FDA-approved medications requiring boxed warnings due to serious side effects like pulmonary embolism.
Hall reportedly earned approximately $3,805,470 from selling unapproved drugs such as Raloxifene, Tamoxifen, and Pramipexole across state lines.
He misled regulatory agencies like the FDA about his products' true nature by labeling them as “research chemicals” despite intending them for human consumption. Misleading Certificates of Analysis were posted on the Rat’s Army website to assure consumers of product legitimacy and safety.
Hall falsely claimed that no prescription or pharmacy access was needed for purchasing products from Rat’s Army while presenting his company as a “pharmaceutical manufacturing” business without employing a licensed pharmacist or registering with the FDA as required.
The case is being prosecuted by the U.S. Attorney’s Office following an investigation conducted by the FDA.
